Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis – a case series

BACKGROUND: The majority of patients with autoimmune hepatitis (AIH) achieve complete remission with established treatment regiments. In patients with intolerance or insufficient response to these drugs, the remaining options are limited and novel treatment approaches necessary. In primary biliary c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolev, Mirjam, Sarbu, Adela-Cristina, Möller, Burkhard, Maurer, Britta, Kollert, Florian, Semmo, Nasser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883290/
https://www.ncbi.nlm.nih.gov/pubmed/36718275
http://dx.doi.org/10.1016/j.jtauto.2023.100189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883290/
https://www.ncbi.nlm.nih.gov/pubmed/36718275
http://dx.doi.org/10.1016/j.jtauto.2023.100189

Ejemplares similares